Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Medtronic
Moodys
McKinsey
Colorcon

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for HZT-501

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug HZT-501: Sponsors, patents, clinical trial progress

HZT-501 is an investigational drug.

There have been 4 clinical trials for HZT-501. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2007.

The most common disease conditions in clinical trials are Low Back Pain, Back Pain, and Arthritis, Rheumatoid. The leading clinical trial sponsors are Horizon Pharma Ireland, Ltd., Dublin Ireland and [disabled in preview].

Recent Clinical Trials for HZT-501
TitleSponsorPhase
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug TreatmentHorizon Pharma Ireland, Ltd., Dublin IrelandPhase 3
Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216)Horizon Pharma Ireland, Ltd., Dublin IrelandPhase 3
Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) TreatmentHorizon Pharma Ireland, Ltd., Dublin IrelandPhase 3

See all HZT-501 clinical trials

Clinical Trial Summary for HZT-501

Top disease conditions for HZT-501
Top clinical trial sponsors for HZT-501

See all HZT-501 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
McKinsey
Moodys
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.